Federation Des Caisses Desjardins Du Quebec Medicenna Therapeutics Corp. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Aug 30, 2024
SELL
$1.91 - $3.05 $1,910 - $3,050
-1,000 Closed
0 $0
Q2 2021

Aug 30, 2024
BUY
$2.97 - $4.28 $2,970 - $4,280
1,000 New
1,000 $2.98 Million
Q1 2021

Aug 30, 2024
SELL
$3.5 - $4.56 $3,850 - $5,016
-1,100 Reduced 22.0%
3,900 $15.7 Million
Q3 2020

Aug 30, 2024
BUY
$3.55 - $4.67 $17,750 - $23,350
5,000 New
5,000 $20.4 Million

Others Institutions Holding MDNA

# of Institutions
3
Shares Held
863K
Call Options Held
0
Put Options Held
0
View Full List

About Medicenna Therapeutics Corp.

MDNA Quotes by TradingView
  • Ticker MDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,637,504
  • Market Cap $21.6M
  • Description
  • Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...
More about MDNA
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email